Firms link on products for orthopaedic surgery:
This article was originally published in Clinica
Genzyme Biosurgery, which develops polymer-based materials to support bone growth, and Exactech, a manufacturer of human-derived bone materials for orthopaedic implants, are to work together in developing products for use in orthopaedic surgery. Genzyme Biosurgery, of Cambridge, Massachusetts, has granted Exactech an exclusive worldwide licence to use its Focal synthetic bioabsorbable polymer technologies. It will supply materials and polymer expertise to Gainesville, Florida-based Exactech, which will handle the manufacture and distribution of products resulting from the collaboration.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.